1 | Acetylcysteine | Acetylcysteine 12件: Acetylcysteine; Acetylcysteine effervescent tablets; Acetylcysteine sodium; Fluimucil (acetylcysteine); Glatiramer acetate, n-acetylcysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetylcysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); | 1件: D00221 D00221 💬 |
- |
- |
006 17件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 90, 94, 111, 164, 193, 233, 298, 299 💬 |
2 | Adenosine | 2-cda, 2-chloro-2'-deoxy-beta-d-adenosine 19件: 2-cda, 2-chloro-2'-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2'-deoxy-ß-d-adenosine; 2-cda, 2-chloro-2?-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2?-deoxy-ß-d-adenosine; 2-cda, 2-chloro-2’-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2'-deoxy-beta-d-adenosine (2-cda); 2-chloro-2'-deoxy-ß-d-adenosine (2-cda); 2-chloro-2'-deoxyadenosine (2-cda); 2-chloro-2'-deoxyadenosine, 2cda; 2-chloro-2?-deoxy-beta-d-adenosine; 2-chloro-2?-deoxy-ß-d-adenosine; 2-chloro-2’-deoxy-beta-d-adenosine; 2-chloro-2’-deoxy-beta-d-adenosine (2-cda); 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2’-deoxy-ß-d-adenosine (2-cda); 2-chloro-2’-deoxyadenosine (2-cda); Adenosine; Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv); | 1件: D00045 D00045 💬 |
4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 3件: 13, 58, 65 💬 |
3 | Atorvastatin | Atorvastatin 9件: Atorvastatin; Atorvastatin 10mg; Atorvastatin 20mg; Atorvastatin calcium; Atorvastatin tablet 20 mg; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Lisinopril, losartan, and atorvastatin; Untreated to atorvastatin treatment; | 3件: D00258 D00258
D00887 D00887
D07474 D07474 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
4 | Bluefish | Bluefish 2件: Bluefish; Losartan bluefish 50 mg; | - |
- |
- |
058 1件: 58 💬 |
5 | Candesartan | Candesartan 3件: Candesartan; Candesartan and cilnidipine; Candesartan plus non-ccb agents; | 1件: D00522 D00522 💬 |
1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 2件: 58, 67 💬 |
6 | Cyclosporine | Atg+cyclosporine 26件: Atg+cyclosporine; Atg+rapamune+cyclosporine; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide,cyclosporine a; Cyclosporine; Cyclosporine (gengraf ); Cyclosporine (usan); Cyclosporine 5 mg/kg bid days 0-14; Cyclosporine a; Cyclosporine a (csa); Cyclosporine a dry powder inhalation (drug); Cyclosporine combine with mycophenolate mofetil; Cyclosporine inhalation solution; Cyclosporine inhalation solution (cis); Cyclosporine oral product; Cyclosporine pill; Cyclosporine vs infliximab; Cyclosporine-a; Device: cyclosporine a; Liposomal aerosol cyclosporine; Liposomal cyclosporine a; Liposomal cyclosporine a 10 mg; Liposomal cyclosporine a 5 mg; Oral cyclosporine; Rabbit atg, cyclosporine, levamisole; Twice-daily dosage with 0.5% cyclosporine-a eyedrops; | 1件: D00184 D00184 💬 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
7 | Diltiazem | Diltiazem 3件: Diltiazem; Diltiazem gel 2%; Diltiazem hydrochloride; | 3件: D00616 D00616
D03830 D03830
D07845 D07845 💬 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 58, 86 💬 |
8 | Dobutamine | Dobutamine 2件: Dobutamine; Other: dobutamine; | 4件: D00632 D00632
D03879 D03879
D03880 D03880
D03881 D03881 💬 |
1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 3件: 57, 58, 215 💬 |
9 | Eleclazine | Eleclazine 1件: Eleclazine; | 1件: D11155 D11155 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
058 1件: 58 💬 |
10 | Ethanol | Andrographis paniculata (ethanol extract) 11件: Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate; Other: physalis angulata ethanol extract; Treprostinil diethanolamine; | 4件: D00068 D00068
D02798 D02798
D04855 D04855
D06542 D06542 💬 |
- |
- |
013 7件: 13, 51, 58, 97, 279, 280, 298 💬 |
11 | Flunarizine | - | 2件: D01303 D01303
D07971 D07971 💬 |
3件: CACNA1G, CACNA1H, CACNA1I 💬 |
Aldosterone synthesis and secretion 8件: Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus |
058 4件: 58, 86, 149, 215 💬 |
12 | Gadolinium | Device: magnetic resonance imaging (mri) with gadolinium enhancement 10件: Device: magnetic resonance imaging (mri) with gadolinium enhancement; Device: magnetic resonance imaging (mri) without gadolinium enhancement; Diagnostic test: cardiac mri (gadolinium enhanced); Gadolinium; Gadolinium contrast; Gadolinium for abdomen; Gadolinium for lower back; Gadolinium-based contrast; Other: uspio mri - gadolinium mri; Standard gadolinium contrast; | - |
- |
- |
013 6件: 13, 34, 46, 58, 65, 86 💬 |
13 | Levocarnitine | Levocarnitine 4件: Levocarnitine; Levocarnitine propyl hydrochloride; Valproate, levocarnitine; Valproic acid and levocarnitine; | 3件: D02030 D02030
D02176 D02176
D04713 D04713 💬 |
- |
- |
003 10件: 3 , 5 , 13, 53, 58, 96, 97, 265, 298, 316 💬 |
14 | Losartan | Lisinopril, losartan, and atorvastatin 12件: Lisinopril, losartan, and atorvastatin; Losartan; Losartan and atenolol or propranolol; Losartan and nebivolol; Losartan and other angiotensin receptor blockers; Losartan bluefish 50 mg; Losartan hexal; Losartan potasico; Losartan potassium; Losartan tablets & qingremoshen granule; Other: losartan; Sildenafil and losartan; | 2件: D00357 D00357
D08146 D08146 💬 |
1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
15 | Mangafodipir | Mangafodipir 3件: Mangafodipir; Mangafodipir (teslascan); Other: mangafodipir trisodium; | 1件: D08262 D08262 💬 |
- |
- |
013 2件: 13, 58 💬 |
16 | Mavacamten | Mavacamten 1件: Mavacamten; | - |
- |
- |
058 1件: 58 💬 |
17 | Medical air | Medical air 5件: Medical air; Medical air (sham o2); Medical air vs oxygen; Other: medical air; Sham o2 (medical air); | - |
- |
- |
003 8件: 3 , 51, 58, 85, 86, 97, 193, 299 💬 |
18 | Methamidophos | - | - |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
19 | Metoprolol | Metoprolol 8件: Metoprolol; Metoprolol succinate; Metoprolol succinate + doxazosin; Metoprolol tartrate 50 mg; Metoprolol tartrate oral tablet; Metoprololsuccinat orion 25mg; Metoprololsuccinat ”orion” 25mg; Tesofensine/metoprolol; | 3件: D00601 D00601
D02358 D02358
D05011 D05011 💬 |
1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 6件: 17, 57, 58, 113, 193, 226 💬 |
20 | Midodrine | Midodrine 2件: Midodrine; Midodrine hydrochloride; | 2件: D01307 D01307
D08220 D08220 💬 |
3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 3件: 6 , 17, 58 💬 |
21 | Nesiritide | - | 1件: D05147 D05147 💬 |
1件: NPR1 💬 |
Aldosterone synthesis and secretion 10件: Aldosterone synthesis and secretion, Metabolic pathways, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 2件: 46, 58 💬 |
22 | Nitrate | Gallium nitrate 11件: Gallium nitrate; Isosorbide dinitrate; Isosorbide dinitrate 20 mg; Isosorbide dinitrate 40 mg; Isosorbide dinitrate 60 mg; Isosorbide dinitrate 80 mg; Nitrate; Other: ibuprofen and isosorbide dinitrate combination; Pilocarpine nitrate 5%; Sodium nitrate; Sodium nitrate - double dose; | 1件: D02313 D02313 💬 |
- |
- |
058 3件: 58, 113, 299 💬 |
23 | Perhexiline | Device: use of bioanalytical assay to monitor plasma levels of perhexiline 2件: Device: use of bioanalytical assay to monitor plasma levels of perhexiline; Perhexiline; | 2件: D05442 D05442
D08340 D08340 💬 |
8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway 45件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 2件: 58, 272 💬 |
24 | Phosphorus | Other: 31-phosphorus rmn spectroscopy 2件: Other: 31-phosphorus rmn spectroscopy; Phosphorus; | - |
- |
- |
008 2件: 8 , 58 💬 |
25 | Piperazine | 1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride 2件: 1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride; Piperazine; | 6件: D00807 D00807
D01393 D01393
D02127 D02127
D02145 D02145
D05486 D05486
D06224 D06224 💬 |
- |
- |
058 1件: 58 💬 |
26 | Pirfenidone | Pirfenidone 7件: Pirfenidone; Pirfenidone (pfd); Pirfenidone 267 mg [esbriet]; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Pirfenidoneone; Sub-study: pirfenidone; | 1件: D01583 D01583 💬 |
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
27 | Pyrazole | (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide 2件: (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide; Pyrazole; | - |
- |
- |
028 4件: 28, 46, 58, 75 💬 |
28 | Ranolazine | Ranolazine 7件: Ranolazine; Ranolazine 1000 mg; Ranolazine 1000 mg pr tablets; Ranolazine 500 mg; Ranolazine 500 mg pr tablets; Ranolazine 750 mg pr tablets; Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die; | 2件: D05700 D05700
D05701 D05701 💬 |
- |
- |
002 6件: 2 , 58, 86, 96, 113, 114 💬 |
29 | Regadenoson | Regadenoson 1件: Regadenoson; | 1件: D05711 D05711 💬 |
1件: ADORA2A 💬 |
Alcoholism 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
058 1件: 58 💬 |
30 | Sacubitril | Sacubitril 3件: Sacubitril; Sacubitril valsartan; Sacubitril/valsartan; | 1件: D10225 D10225 💬 |
1件: MME 💬 |
Alzheimer disease 4件: Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system |
058 1件: 58 💬 |
31 | Sodium nitrate | Sodium nitrate 2件: Sodium nitrate; Sodium nitrate - double dose; | - |
- |
- |
058 2件: 58, 113 💬 |
32 | Spironolactone | Ambrisentan plus spironolactone 5件: Ambrisentan plus spironolactone; Spironolactone; Spironolactone (drug); Spironolactone and conivaptan; Spironolactone captopril carvedilol; | 1件: D00443 D00443 💬 |
1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
33 | Triethylenetetramine | - | - |
- |
- |
058 2件: 58, 171 💬 |
34 | Trimetazidine | Trimetazidine 3件: Trimetazidine; Trimetazidine dihydrochloride; Trimetazidine dihydrochloride 20mg; | 2件: D01606 D01606
D08642 D08642 💬 |
- |
- |
058 2件: 58, 86 💬 |
35 | Valsartan | Benazepril, valsartan and fluvastatin 5件: Benazepril, valsartan and fluvastatin; Enalapril valsartan methylprednisone; Sacubitril valsartan; Sacubitril/valsartan; Valsartan; | 1件: D00400 D00400 💬 |
1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 7件: 57, 58, 66, 75, 218, 222, 224 💬 |